There isn’t a cure for cancer yet, but if everyone can come together, we may find that cure sooner rather than later. One biotech company that is trying to solve cancer is Qualigen Therapeutics. With their oncology therapeutics pipeline, they could be onto something with their leading asset QN-302. Join Ammon Rivera as he talks to the Chief Medical Officer of Qualigen Therapeutics, Tariq Arshad, MD, about where they are right now in their therapeutics pipeline. Learn why cancer is the greatest injustice and how Tariq is fighting to stop it. Find out more about their research in Qualigen Therapeutics when it comes to killing these cancer cells. Let's all come together and stop cancer. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
AI Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
A Journey From Investment Banker To The CEO Of A Biotech Developing Cancer Therapy With Bryan Kobel
Biotech Chief People Officer Discusses How To Build Company Culture
Qualigen Therapeutics: How Do You Develop A Successful Therapeutics Pipeline In Oncology With Amy Broidrick
Mapping The Human Immune System: Using AI To Change Drug Development With Noam Solomon
Free AI-powered recaps of The Best Of BioTech IQ and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.